Intranasal challenge drug
#5879
Phase 3 small_molecule completed
Quick answer
Intranasal challenge drug for Heroin Dependence is a Phase 3 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Heroin Dependence
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed